QD Quadramed Corp.

QuadraMed� Corporation (Amex:QD) today announced that sales bookings for the year ended December 31, 2006 totaled $84 million, representing a 25 percent increase compared to the sales bookings reported for the same 12-month period in 2005. �Again in 2006, our industry-leading solutions were in high demand by healthcare organizations nationwide,� said Keith B. Hagen, QuadraMed President and CEO. �Our sales team responded by turning that demand into solid sales bookings growth of over 25 percent. QuadraMed also benefited from positive client references for our Access and Identity Management, Care, Health Information and Revenue Cycle Management solutions, and from our continued high KLAS ratings. Looking forward, I�m convinced we have the right people and the right solutions in place to achieve our long-term objectives.� Sales bookings highlights for QuadraMed�s 2006 fiscal year include: Sales bookings totaling $84 million compared to $67 million in fiscal 2005 Two new enterprise Affinity� HIS (Hospital Information System) sales A $3.4M contract with Inova Health System for Smart Identity Management Solutions�, and a significant overall increase in related Identity Management solutions bookings Strong bookings for Quantim� Health Information Management (HIM) solutions A $20.5M contract for HIM related products and services with the Department of Veterans Affairs to provide an advanced solution for all 147 VA hospitals nationwide Sales bookings include: Software license, installation, one year of maintenance and hardware, if any, for all perpetual software sales The total contract value of a term license deal (typically one or three years), whether a renewal or new name contract Full value of a service contract, whether a renewal or new name contract Sales bookings exclude renewals of existing maintenance agreements related to perpetual software licenses. �While the 2007 revenue impact from 2006 sales bookings depends on the type of solution or service, the length of implementation and whether it is net new business or a renewal of existing business, there is no doubt that this strong year-on-year sales increase is further evidence of the success QuadraMed is enjoying,� said Mr. Hagen. �We provide a wide range of solutions and services that support the full Care-Based Revenue Cycle�. All of our solutions and services are equally important to our Company�s success. And this sales success is being powered by our broad portfolio of industry-leading products, also highlighting the fact that QuadraMed is much more than Affinity.� For information about all QuadraMed products and services, visit www.quadramed.com or call 800-393-0278. About QuadraMed Corporation QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. As evolving reimbursement scenarios challenge healthcare organizations to leverage quality of care into payment, clients committing to QuadraMed�s care-based solutions can realize market leading financial performance. Using QuadraMed�s end-to-end solutions to optimize the patient experience and leverage quality of care into payment, our clients can receive the proper reimbursement, in the shortest time, at the lowest administrative cost. Behind our products and services is a staff of almost 600 professionals whose experience and dedication to service have earned QuadraMed the trust and loyalty of customers at approximately 2,000 healthcare provider facilities. To find out more about QuadraMed, visit www.quadramed.com. Cautionary Statement on Risks Associated with QuadraMed�s Forward-Looking Statements This press release contains forward-looking statements, as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed�s actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed�s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC�s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed, Affinity and Quantim are registered trademarks of QuadraMed Corporation. Care-Based Revenue Cycle and Smart Identity Management Solutions are trademarks of QuadraMed Corporation. All other trademarks are the property of their respective holders.